301 research outputs found
Increased Platelet Reactivity Due to Platelet Receptor Polymporphisms? Not in the Real World
n/
Quantitative blush evaluator (QuBE) accurately quantifies microvascular dysfunction in patients with ST-Elevation Myocardial Infarction; comparison with Cardiovascular Magnetic Resonance
Clinical impact of routine angiographic follow-up after percutaneous coronary interventions on unprotected left main
Background: Patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stent (DES) on unprotected left main (ULM) represent a complex subset. The role of routine coronary angiography at follow up in this subset remains debated.
Methods: At the documented center, all patients undergoing successful PCI on ULM lesions performing angiographic follow-up is suggested, but adherence to such a recommendation is inhomogeneous. Consecutive patients undergoing DES PCI on ULM were enrolled and experienced no adverse events during the first 6 months. Patients were then allocated to two groups: those undergoing routine control angiography (CA) and those undergoing clinical follow-up (CF). Primary endpoint was major adverse cardiac events (MACE) defined as cardiac death, myocardial infarction and urgent repeat target vessel revascularization.
Results: A total of 190 patients underwent successful DES implantation on ULM and the study population was without early events. CA was performed at 6 months after the index procedure in 91 (48%) patients. After 35 ± 21 months, MACE rates were significantly more common in the CF group as compared with the CA group (16.2% vs. 4.3%, p = 0.009). At multivariable analysis, CA was associated with reduced MACE risk (HR 0.13, 95% CI 0.1–0.7, p = 0.028). Of note, this was mainly driven by higher cardiac death rate in those undergoing CF than in those undergoing CA (p = 0.01).
Conclusions: CA after complex PCI, such as ULM PCI, is associated with reduced MACE. Such an observation calls for appropriately designed randomized trials
Clinical impact of routine angiographic follow-up after percutaneous coronary interventions on unprotected left main
Background: Patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stent (DES) on unprotected left main (ULM) represent a complex subset. The role of routine coronary angiography at follow up in this subset remains debated. Methods: At the documented center, all patients undergoing successful PCI on ULM lesions performing angiographic follow-up is suggested, but adherence to such a recommendation is inhomogeneous. Consecutive patients undergoing DES PCI on ULM were enrolled and experienced no adverse events during the first 6 months. Patients were then allocated to two groups: those undergoing routine control angiography (CA) and those undergoing clinical follow-up (CF). Primary endpoint was major adverse cardiac events (MACE) defined as cardiac death, myocardial infarction and urgent repeat target vessel revascularization. Results: A total of 190 patients underwent successful DES implantation on ULM and the study population was without early events. CA was performed at 6 months after the index procedure in 91 (48%) patients. After 35 \ub1 21 months, MACE rates were significantly more common in the CF group as compared with the CA group (16.2% vs. 4.3%, p = 0.009). At multivariable analysis, CA was associated with reduced MACE risk (HR 0.13, 95% CI 0.1\u20130.7, p = 0.028). Of note, this was mainly driven by higher cardiac death rate in those undergoing CF than in those undergoing CA (p = 0.01). Conclusions: CA after complex PCI, such as ULM PCI, is associated with reduced MACE. Such an observation calls for appropriately designed randomized trials
O INCIDENTE DE RESOLUÇÃO DE DEMANDAS REPETITIVAS NO NOVO CPC: O COMMON LAW NO DIREITO PROCESSUAL BRASILEIRO
Reiteradamente, na atividade jurisdicional, evidenciam-se decisões divergentes, mesmo quando se trata de casos análogos, quando não idênticos. Esta realidade afronta inequivocamente os pilares do Direito, assecuratórios da segurança jurídica, da isonomia e, perfunctoriamente, a Justiça no caso concreto. Sob estes aspectos, emergem diversos pareceres de doutos juristas que, claramente influenciados pela doutrina britânica e estadunidense, concebem a necessidade de adoção de precedentes obrigatórios a vincular determinadas questões de direito. Certo é que a incidência dessas correntes doutrinárias advindas do common Law se verifica ainda bastante restrita nos tribunais pátrios, vez que inexiste, no ordenamento jurídico brasileiro, instrumento de vinculação cogente entre a atividade jurisprudencial. Contudo, é de ressalvar a presença das Súmulas Vinculantes, primeiro brado brasileiro concreto acerca de traços do Direito Jurisprudencial. Mais uma vez, apesar da importância deste instituto, observa-se que seus efeitos ainda são limitados, posto que é de consolidação exclusiva pela Suprema Corte Brasileira. O Projeto do Novo Código de Processo Civil permitirá que se supere décadas de existência de casos em que eram proferidas decisões finais divergentes provenientes de casos similares, ao consagrar o Incidente de Resolução de Demandas Repetitivas, instrumento de uniformização
Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study
Background: Cannabinoids may be useful to treat pain, epilepsy and spasticity, although they may bear an increased risk of cardiovascular events. This study aims to evaluate the cardiovascular safety of nabiximols, a cannabis-based drug, in patients with spasticity following stroke, thus presenting an increased cardiovascular risk.
Methods: This is an ancillary study stemming from the SativexStroke trial: a randomized double-blind, placebo-controlled, crossover study aimed at assessing the effect of nabiximols on post-stroke spasticity. Patients were treated with nabiximols oromucosal spray or placebo and assessed before and after two phases of 1-month duration each. Only the phase with the active treatment was considered for each patient who completed the study. The average values of blood pressure (diastolic, systolic, differential) and heart rate from the first 5 days of the phase (lowest nabiximols dosage) were compared to the average values recorded during the last 5 days at the end of the phase (highest nabiximols dosage). Baseline comparisons between gender, stroke type and affected side and correlation between age and blood pressure and heart rate were performed. The study was registered with the EudraCT number 2016-001034-10.
Results: Thirty-four patients completed the study and were included in the analysis. Thirty-one were taking antihypertensive drugs and, among these, 12 were taking beta-blockers. During the study, no arrhythmic events were recorded, blood pressure and heart rate did not show pathological fluctuations, and no cardiovascular or cerebrovascular events occurred. At baseline blood pressure and heart rate were comparable concerning gender, stroke type and affected side. A significant direct correlation emerged between differential blood pressure and age and an inverse correlation between diastolic blood pressure and age. No correlation emerged between systolic blood pressure or heart rate and age. Blood pressure and heart rate did not change during nabiximols treatment compared to the baseline condition.
Conclusion: This ancillary study adds evidence that, in patients who already underwent a cerebrovascular accident, nabiximols does not determine significant blood pressure and heart rate variation or cardiovascular complications. These data support the cardiovascular safety of nabiximols, encouraging more extensive studies involving cannabinoids characterized by slow absorption rates
Peripheral levels of circulating progenitor cells correlate with area at risk and microvascular obstruction at cardiac magnetic resonance imaging in patients with ST-elevation myocardial infarction
- …